Annals of Oncology - Journals World

Journal Name: Annals of Oncology

Journal Type: Q1

ISSN: 09237534, 15698041

Country: United Kingdom

Subject Area and Category: Medicine Hematology Medicine (miscellaneous) Oncology

Publisher: Elsevier Ltd

Research Ranking: 13

Publication Type: Journals

H-Index: 294

Coverage: 1990-2023

Editors-in-Chief: Dirk Arnold , Sandro Pignata , Kunihiro Tsukasaki , Nicholas McGranahan , Axel Hinke , Philippe Aftimos , Emilio Bria , Philippa Corrie , Tanya Dorff , Alexandru Eniu , Peter S. Grimison , Michail Ignatiadis , David H. Ilson , Filip Janku , Naomi Kiyota , Yohann Loriot , Carmel Pezaro , Sophie Postel-Vinay , Amanda Psyrri , Mario Scartozzi , Alberto Sobrero , Guru Sonpavde , Vivek Subbiah , Christos Sotiriou , Johan Vansteenkiste , Paolo Boffetta , Pagona Lagiou , Thomas Helleday , Diana Giannarelli , Matti Aapro , Joaquim Bellmunt , Fortunato Ciardiello , Giuseppe Curigliano , Sherene Loi , Funda Meric-Bernstam , Silvia Novello , Atsushi Ohtsu , Yi-Long Wu , Yi-Long Wu

Research Impact Score: 55.4

Impact Factor: 56.7

SCIMAGO SJR: 13.942

APC Cost: $5080

Homepage: https://www.journals.elsevier.com/annals-of-oncology

Submission Link: https://www.journals.elsevier.com/annals-of-oncology

Contact Email: annals1@esmo.org

Address: 1600 John F. Kennedy Boulevard, Suite 1600. Philadelphia, PA 19103-2899. USA.

Overview

The Annals of Oncology is a prestigious peer-reviewed medical journal that plays a pivotal role in advancing the field of oncology. As a leading source of knowledge for oncologists, researchers, and healthcare professionals, it consistently publishes cutting-edge research, reviews, and clinical trials on a wide range of cancer-related topics. Established in 1990, this journal is renowned for providing high-quality content on the latest developments in cancer treatment, prevention, and diagnosis.

Scope and Focus

The journal’s primary focus is on clinical oncology, but it also encompasses various subfields, including cancer biology, molecular oncology, immunotherapy, palliative care, and epidemiology. Articles published in Annals of Oncology cover a broad spectrum of cancer types, from solid tumors like breast, lung, and colorectal cancer, to hematological malignancies such as leukemia and lymphoma.

A unique feature of the journal is its emphasis on translational research, which bridges the gap between laboratory findings and clinical applications. This focus ensures that the research published is not only theoretically significant but also practically applicable, offering valuable insights into improving patient outcomes.

Research and Clinical Trials

Annals of Oncology is renowned for its publication of groundbreaking clinical trials that help shape the future of cancer treatment. These studies often explore innovative therapies, including targeted therapies, immunotherapies, and personalized medicine, which are revolutionizing cancer care. Additionally, the journal provides comprehensive reports on novel drug development, treatment regimens, and emerging technologies that contribute to early cancer detection and more effective treatments.

The journal also publishes meta-analyses, systematic reviews, and expert consensus statements, providing readers with well-rounded perspectives on specific issues in oncology. These resources are invaluable for healthcare professionals seeking evidence-based recommendations and up-to-date clinical guidelines.

Impact Factor and Recognition

The Annals of Oncology consistently ranks highly in terms of its impact factor, a measure of the journal's influence in the field of oncology. It is one of the top journals in terms of both citation and readership, which reflects its significant contribution to the global oncology community. The high visibility and credibility of the journal ensure that its articles are widely read and referenced by clinicians, researchers, and policy-makers around the world.

Online Presence and Accessibility

As part of its commitment to advancing oncology research and education, Annals of Oncology has a strong online presence. The journal offers easy access to its content through its website, providing full-text articles, abstract views, and the latest research developments. The online platform also facilitates quicker publication cycles, ensuring that critical research findings reach the global healthcare community in a timely manner.

About

The Annals of Oncology is a prestigious, peer-reviewed scientific journal that has established itself as a key resource for oncologists, researchers, and healthcare professionals involved in cancer care. Published monthly, the journal focuses on providing in-depth insights into the latest developments in cancer research, clinical oncology, and the advancements in cancer treatment. It plays a vital role in the global oncology community by disseminating high-quality research and offering evidence-based practices for clinicians and researchers alike.

Key Areas of Focus in Annals of Oncology

The journal covers a wide range of topics related to cancer, including but not limited to:

Cancer Treatment Advances: With a strong emphasis on cutting-edge therapies, Annals of Oncology publishes articles on the latest breakthroughs in cancer treatments. This includes immunotherapy, targeted therapies, chemotherapy, and radiation therapy. It also explores new methods for improving treatment outcomes and minimizing side effects.
Clinical Trials and Research: Clinical trials are an essential part of advancing cancer treatment, and Annals of Oncology provides comprehensive coverage of ongoing and completed trials. The journal often includes phase I-III trial results, offering valuable data that can shape treatment protocols and influence the clinical management of cancer.
Oncology Diagnostics: The journal highlights advancements in diagnostic tools, such as molecular profiling, imaging techniques, and biomarker discovery, which are critical for early cancer detection and personalized treatment planning.
Cancer Epidemiology and Prevention: Understanding the epidemiological trends of cancer and implementing effective prevention strategies are crucial to reducing cancer incidence worldwide. Annals of Oncology regularly publishes studies on cancer risk factors, screening methods, and public health initiatives aimed at preventing cancer.
Personalized Medicine in Oncology: One of the journal’s key areas of interest is personalized medicine, focusing on how genetic, molecular, and environmental factors influence cancer treatment decisions. Articles often explore the growing importance of precision oncology and how genomic data can guide targeted therapies tailored to individual patients.

Why Annals of Oncology is a Critical Resource for Oncologists

The Annals of Oncology is a trusted publication for oncologists worldwide due to its rigorous peer-review process and its commitment to publishing high-quality, impactful research. For healthcare providers and researchers, staying updated with the latest findings in cancer care is essential for improving patient outcomes. The journal provides a platform for the dissemination of groundbreaking research that influences clinical practices, shaping the future of cancer treatment.

Global Impact and Accessibility

As one of the most highly cited oncology journals globally, Annals of Oncology reaches a vast audience. Its content is accessible to clinicians, researchers, and students, helping to bridge the gap between laboratory discoveries and clinical applications. The journal’s impact factor and high citation rates reflect its importance and contribution to advancing cancer care and research.

Moreover, Annals of Oncology is available online, ensuring easy access to research findings, reviews, and special articles. The journal’s website also offers features such as early online publication of high-impact articles, making it an up-to-date and reliable source of information.

Scope

The Annals of Oncology is one of the most renowned and influential journals in the field of oncology. It serves as a critical platform for publishing high-quality research and advancements in cancer treatment, prevention, and management. The journal offers valuable insights for clinicians, researchers, and healthcare professionals working in the field of oncology. As a leading publication in the field, Annals of Oncology plays a pivotal role in advancing our understanding of cancer biology, providing evidence-based approaches, and improving patient outcomes.

Focus Areas and Key Topics

The scope of the Annals of Oncology covers a wide array of cancer-related disciplines, making it an essential resource for oncologists and medical researchers worldwide. Its primary focus is to publish groundbreaking research in various areas of oncology, including but not limited to:

Cancer Biology and Molecular Pathways: The journal features studies on the molecular mechanisms underlying cancer, exploring the genetic mutations, signaling pathways, and cellular processes that drive tumorigenesis. Research in this area provides insights into potential biomarkers for early detection and targets for innovative therapies.
Clinical Oncology: Clinical oncology is a significant area of interest for the Annals of Oncology. The journal publishes research on the diagnosis, treatment, and management of cancers across a wide range of organs and tissues. Topics such as personalized medicine, immunotherapy, chemotherapy, radiotherapy, and surgical interventions are frequently covered. The journal emphasizes evidence-based approaches that improve patient care and treatment outcomes.
Cancer Prevention and Epidemiology: Cancer prevention is an increasingly important topic in the fight against cancer. Annals of Oncology publishes studies focused on the prevention of cancer through lifestyle changes, vaccination, early screening, and other preventive measures. Additionally, epidemiological studies on the global burden of cancer and its impact on different populations are key components of the journal’s scope.
Immuno-Oncology: Immunotherapy has become one of the most promising areas of cancer treatment in recent years. The Annals of Oncology features research on novel immuno-oncology strategies, including checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. These studies aim to explore how the immune system can be harnessed to target and eliminate cancer cells effectively.
Palliative Care and Survivorship: Palliative care is essential for improving the quality of life for patients with advanced cancer. The Annals of Oncology also publishes research on palliative care strategies, symptom management, and psychosocial support for cancer patients. Additionally, survivorship care, including the long-term effects of cancer treatment and strategies for monitoring and supporting survivors, is a critical area of focus.
Oncology Nursing and Multidisciplinary Care: The journal recognizes the importance of a multidisciplinary approach to cancer care. Research related to oncology nursing, the role of allied health professionals, and the integration of different specialties in cancer treatment is a key part of the journal’s scope.

Peer-Reviewed Research and Global Collaboration

As a peer-reviewed journal, Annals of Oncology ensures that all submitted manuscripts undergo a rigorous review process by experts in the field. This process guarantees the quality and credibility of the published research. The journal encourages international collaboration, providing a platform for researchers from diverse geographical regions to share their findings and contribute to the global fight against cancer.